Wall Street Analysts Predict a 39.33% Upside in Auna S.A. (AUNA): Here's What You Should Know
The mean of analysts' price targets for Auna S.A. (AUNA) points to a 39.3% upside in the stock.
Are Medical Stocks Lagging Auna S.A. (AUNA) This Year?
Here is how Auna S.A. (AUNA) and BioNTech SE Sponsored ADR (BNTX) have performed compared to their sector so far this year.
Auna: Cheap Entry Level In Latin American Healthcare Play
Auna is a leading player in the Spanish-speaking Latin America medical industry, focusing particularly on high-complexity diseases, such as cancer. Most SSLA have a highly fragmented and underserved healthcare market, and populations are becoming elderly, demanding more and better services. AUNA stock has been impacted negatively following its IPO process, as local institutional players such as pension funds overbought the stock and had to sell due to regulatory limits.
AUNA Stock Earnings: Auna Misses EPS, Beats Revenue for Q2 2024
Auna (NYSE: AUNA ) just reported results for the second quarter of 2024. Auna reported earnings per share of 3 cents.
